<DOC>
	<DOCNO>NCT01938144</DOCNO>
	<brief_summary>This multicenter , prospective , randomize , double-blind , triple-dummy , parallel group , comparative , study design evaluate efficacy Ibuprofen ( IBU ) 200 mg/ Phenylephrine ( PE ) 10 mg IBU 200 mg/ PE 10 mg/ Chlorpheniramine ( CHLOR ) 4 mg relief symptom common cold flu . The reference product active treatment compare paracetamol ( PARA ) 500 mg .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Two Ibuprofen Combination Products Treatment Common Cold Flu Latin America</brief_title>
	<detailed_description />
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Male female subject 18 year old old time screen . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Subjects must present score 5 high least 2 follow 6 symptom : runny nose , plug nose , sneeze , sore throat , scratchy throat , head congestion WURSS21 assessment , within 36 hour onset symptom . Anyone history chronic allergic rhinitis asthma time screen visit , history chronic recurrent airway disease , infection , frequent complication cold ( otitis medium , sinusitis , bronchitis ) Subjects take prescription nonprescription drug , within last 7 day prior screen , administration IBU , PE , CHLOR , APAP contraindicate , may increase risk associate study participation , may interfere interpretation study result , judgment Investigator . Subjects currently take monoamine oxidase ( MAO ) inhibitor , take MAO inhibitor within 2 month screen . Subjects currently take serotoninselective reuptake inhibitor ( SSRI ) , tricyclic antidepressant ( TCA ) , barbiturate , neuroleptic , take SSRI , TCA , barbiturate , neuroleptic within 14 day screen . Subjects hypersensitivity IBU , PE , CHLOR APAP .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Common cold</keyword>
	<keyword>efficacy</keyword>
	<keyword>symptom</keyword>
	<keyword>Wisconsin Upper Respiratory Symptom Survey - 21</keyword>
	<keyword>ibuprofen</keyword>
	<keyword>phenylephrine</keyword>
	<keyword>pseudoephedrine</keyword>
</DOC>